Form 8-K - Current report:
SEC Accession No. 0001493152-25-008538
Filing Date
2025-02-27
Accepted
2025-02-27 16:47:00
Documents
14
Period of Report
2025-02-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40141
2 ex10-1.htm EX-10.1 67369
  Complete submission text file 0001493152-25-008538.txt   297990

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE thar-20250221.xsd EX-101.SCH 3021
4 XBRL LABEL FILE thar-20250221_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE thar-20250221_pre.xml EX-101.PRE 22363
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3791
Mailing Address 245 MAIN STREET SUITE 204 CHESTER NJ 07930
Business Address 1200 ROUTE 22 EAST BRIDGEWATER NJ 08807 302-743-2995
Tharimmune, Inc. (Filer) CIK: 0001861657 (see all company filings)

EIN.: 842642541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41210 | Film No.: 25680065
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)